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Abstract 26 
Objective: To quantify the risk of hospital admission in relation to fine increments in body mass 27 
index (BMI).    28 
Design, setting and participants:  Population-based prospective cohort study of 246,361 29 
individuals aged ≥45 years, from New South Wales, Australia, recruited from 2006 to 2009. Self-30 
reported data on BMI and potential confounding/mediating factors were linked to hospital 31 
admission and death data. 32 
Main outcomes: Cox-models were used to estimate the relative risk (RR) of incident all-cause 33 
and diagnosis-specific hospital admission (excluding same day) in relation to BMI. 34 
Results: There were 61,583 incident hospitalisations over 479,769 person-years (py) of 35 
observation. In men, hospitalisation rates were lowest for BMI 20-<25kg/m2 (age-standardised 36 
rate:120/1,000py) and in women for BMI 18.5-<25kg/m2 (102/1,000py); above these levels, 37 
rates increased steadily with increasing BMI; rates were 203 and 183/1,000py, for men and 38 
women with BMI 35-50kg/m2, respectively. This pattern was observed regardless of baseline 39 
health status, smoking status and physical activity levels.  After adjustment, the RRs (95% 40 
confidence interval) per 1kg/m2 increase in BMI from ≥20kg/m2 were 1.04(1.03 to 1.04) for men 41 
and 1.04(1.04 to 1.05) for women aged 45-64; corresponding RRs for ages 65-79 were 42 
1.03(1.02 to 1.03) and 1.03(1.03 to 1.04); and for ages ≥80 years, 1.01(1.00 to 1.01) and 43 
1.02(1.01 to 1.02). Hospitalisation risks were elevated for a large range of diagnoses, including 44 
a number of circulatory, digestive, musculoskeletal and respiratory diseases, while being 45 
protective for just two—fracture and hernia . 46 
Conclusions: Above normal BMI, the relative risk of hospitalisation increases with even small 47 
increases in BMI, less so in the elderly. Even a small downward shift in BMI, among those who 48 
are overweight not just those who are obese, could result in a substantial reduction in the risk of 49 
hospitalisation. 50 
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Introduction 55 
 56 
Obesity rates have doubled or tripled in many countries over the past three decades, and in 57 
almost half of all Organization for Economic Co-operation and Development countries 50% or 58 
more of the population is now overweight or obese.1 It is known that obesity, and to a lesser 59 
extent overweight, increases the risk of mortality 2,3 and many chronic diseases.4 However, while 60 
pooled analyses have provided reliable evidence of increasing mortality with incremental 61 
increases in body mass index (BMI) above the normal range2,3 there is more limited information 62 
on the precise relationship between BMI and other important measures of disease and health 63 
service use, such as hospitalisation.5-11 Moreover, while there is considerable evidence 64 
supporting the link between obesity and these outcomes (particularly total hospital use), the 65 
evidence on the risk of outcomes in people who are overweight but not obese is less clear. 66 
Further, there is little on the relationship between incremental changes in BMI and risk of being 67 
hospitalised, and how this might vary according to factors such as age (particularly in older 68 
age), pre-existing disease and other personal characteristics, and on the differential risks for 69 
hospitalisation for specific diagnoses. Studies of the gradient in risk add to the evidence on the 70 
health consequences of above-normal BMI relating to both fatal and non-fatal diseases and the 71 
likely optimal BMI.  72 
 73 
In this study, we aim to quantify the relative risks of hospitalisation according to BMI. We report 74 
on the relationship of increasing increments of BMI to the risk of hospitalisation, including how 75 
the relationship varies by sex and age (particularly older age groups), across levels of smoking 76 
and physical activity, and for hospitalisation for a range of diagnoses.77 
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 78 
Methods 79 
We used data from the 45 and Up Study, an Australian cohort involving 266,724 men and 80 
women aged 45 and over from New South Wales (NSW), Australia. Potential participants were 81 
randomly sampled from the database of Australia’s universal health insurance provider, 82 
Medicare Australia, which provides virtually complete coverage of the general population, and 83 
were invited to take part. There were no exclusion criteria and the Study over-sampled, by a 84 
factor of two, individuals aged 80 years and over and people resident in rural areas.  85 
Participants joining the study completed a baseline questionnaire (between Jan 2006 and April 86 
2009) and gave signed consent for follow-up and linkage of their information to a number of 87 
health-related databases. The overall response rate was 18% meaning that 11% of the entire 88 
NSW population aged 45 and over were included. Further details of the Study are described in a 89 
separate publication,12 and questionnaires can be viewed at http://www.45andup.org.au.  90 
 91 
Baseline survey data from study participants were linked to individual death data from the NSW 92 
Registry of Births, Deaths and Marriages (to Jun 2010), hospital data from the NSW Admitted 93 
Patient Data Collection (Jul 2000–Jun 2010), and cancer data from the NSW Central Cancer 94 
Registry (Jan 2000–date of baseline survey). The NSW Admitted Patient Data Collection 95 
includes records of all hospitalisations in NSW, dates of admission and discharge, and the 96 
primary and additional reasons for admission (coded using ICD-10-AM).13 The NSW Central 97 
Cancer Registry contains information on type of cancer diagnosis and date of diagnosis, and the 98 
NSW Registry of Births, Deaths and Marriages includes information on the date of death.  Data 99 
were linked probabilistically by the Centre for Health Record linkage using personal information 100 
(including full name, date of birth, sex and address), and quality assurance data show false 101 
positive and negative rates for data linkage of <0.5% and <0.1%, respectively.14 102 
 103 
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The main exposure, BMI, was calculated from weight and height as self-reported on the 104 
baseline survey. Because of the increased risk of measurement error in extreme BMI 105 
categories, and consistent with previous well-known studies (e.g. 2,3), participants with 106 
BMI>=50kg/m2 or BMI<15kgm2 were excluded.  BMI was then categorised using the following 107 
cut-points (WHO weight classification15 in brackets): 15– (underweight); 18.5–, 20– and 22.5– 108 
(normal weight); 25–and 27.5– (overweight); 30– 32.5– (obese class I) and 35– (obese class II-109 
III). Data on potential confounding and modifying factors were derived from self-reported data 110 
from the baseline questionnaire.  111 
 112 
The main outcome of interest was incident hospitalisation, defined as the first hospital 113 
admission after recruitment into the study which involved at least one night in hospital (i.e. day 114 
admissions to hospital were excluded), ascertained through linkage to the Admitted Patient Data 115 
Collection. We also examined incident hospitalisation for specific diagnoses, defined according 116 
to final primary diagnosis at discharge, based on the ICD-10-AM code (specific codes listed in 117 
Table 3). Where the admission was part of a transfer, the primary diagnosis of the first 118 
admission in the transfer was selected. The diagnoses examined in the analysis were selected 119 
based on a priori knowledge of conditions known to be associated with obesity,4 or to be major 120 
contributors to the burden of disease in Australia,16 or if they were among the top 20 diagnoses 121 
in this study (excluding rehabilitation and surgical follow-up care and complications following a 122 
procedure). 123 
 124 
Survival methods were used to analyse the data, using age as the underlying time variable. 125 
Participants were followed from the date of recruitment to either the date of first hospital 126 
admission (any or cause-specific) or death, or June 30 2010 (the last date to which hospital data 127 
were available), whichever occurred first.  Incident hospitalisation rates, standardised using 5-128 
year age groups, were calculated according to baseline BMI. Rates were stratified by sex and 129 
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age group (45–64, 65–79 and 80+ years). We also examined rates stratified by smoking (never, 130 
past and current) given its strong association with both BMI and health outcomes, and by prior 131 
serious illness and tertile of physical activity given the complex relationship between these 132 
factors and BMI, including that they may lie on the causal pathway between BMI and health 133 
outcomes.  Prior history of serious illness was defined as at least one of the following: a cancer 134 
diagnosis in the five years prior to enrolment (excluding non-melanoma skin cancer), 135 
ascertained from the cancer register; a hospital admission within the 5 years prior to enrolment 136 
that included a diagnosis of circulatory disease, diabetes or chronic obstructive pulmonary 137 
disease, ascertained from the hospital admission data; or a doctor diagnosis of either cancer, 138 
heart disease, stroke or diabetes self-reported on the questionnaire. Physical activity was 139 
assessed with the Active Australia questionnaire,17 which has documented reliability and 140 
validity.17,18 A score is generated based on the number of weekly sessions of walking, moderate 141 
and vigorous activity, weighted for intensity. This was categorised into tertiles. Interaction effects 142 
were tested using the likelihood-ratio test, comparing models with and without the interaction 143 
terms.  144 
 145 
Cox regression was used to estimate the hazard ratios (referred to henceforth as relative risks 146 
(RR)) for incident hospitalisation according to BMI. For all-cause hospitalisations, the analyses 147 
were performed separately for men and women and were stratified by age group (45–64, 65–79 148 
and 80+ years). The reference BMI group was 20–22.5kg/m2 and tests for linear trend were also 149 
performed excluding those with a BMI of <20kg/m2. Adjustment was made for potential 150 
confounding variables, including area of residence (major city, regional or remote based on the 151 
Accessibility / Remoteness Index of Australia Plus,19 derived from postcode of residence), 152 
education (six categories from ‘did not complete secondary school’ to university degree), pre-tax 153 
annual household income (seven income brackets, from AUD <$5,000 to $70,000 or more per 154 
year), smoking (never, past and current), alcohol intake (0 / 0–14 / 15 or more drinks per week), 155 
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and private health insurance (additional to universal health insurance). Participants with any 156 
missing values on any of these variables were assigned to a separate category for that variable. 157 
In addition, we performed a sensitivity analysis to examine the possible impact of any potential 158 
reverse causality, i.e. the effect of illness on baseline BMI, by excluding all person-years and 159 
hospitalisations in the first year of follow-up. We also examined the effects of additional 160 
adjustment for country of birth, classified into 13 regions, with a separate category for 161 
‘Australian-born’ based on a modified version of that used in the Global Burden of Disease 162 
Study.20    163 
 164 
For hospitalisations for specific diagnoses, we stratified by age group, but combined males and 165 
females, and used broader BMI categories, comparing rates in overweight (25–<30kg/m2) and 166 
obese (30–50 kg/m2) to normal weight (18.5–<25 kg/m2), in order to retain statistical power, 167 
while adjusting for all confounders including sex. The proportional hazards assumption was 168 
satisfied for all models. All analyses were performed using Stata version 12.0.21  169 
 170 
Ethics approval for this project was obtained from the NSW Population and Health Services 171 
Research Ethics Committee and the Australian National University Human Research Ethics 172 
Committee. 173 
 174 
 175 
Results 176 
After excluding those with BMI <15kg/m2 (n=303) or >50kg/m2 (n=2,463) or missing (n=17,600), 177 
we followed 246,361 participants (92.4%), with the average time between baseline survey and 178 
end of the study period (or death) being 2.3 years (range: 1 day to 4.5 years). 179 
 180 
 9 
 
The characteristics of the sample are shown in Table 1. Just under half the sample (47%) 181 
comprised men, with the majority of participants (62%) aged 45–64 years and 10% aged 80 182 
years or older. Regarding BMI, 62% of the sample were overweight or obese (40% and 22%, 183 
respectively), two-thirds of men (47% overweight and 22% obese) and just over half of the 184 
women (33% overweight and 23% obese); this proportion was considerably lower in those who 185 
were aged 80 years or older (48% overweight/obese).  186 
 187 
There were 61,583 incident hospitalisations over 479,769 person-years of observation; a rate of 188 
128 per 1,000 person years (95% CI: 127 to 129) overall, 143 (95% CI: 142 to 145) in males 189 
and 115 (95% CI: 114 to 8117) in females.  Age-adjusted incident hospitalisation rates 190 
according to BMI are presented in Figure 1. Amongst men, incident hospitalisation rates were 191 
lowest in those with a BMI between 20 and 25kg/m2 (age-adjusted rate of 120 per 1,000 py) and 192 
amongst women with a BMI of between 18.5 and 25kg/m2 (102 per 1,000 py); rates were 193 
highest in the highest BMI category (35–50kg/m2) for both men and women (rates of 203 and 194 
183 per 1,000 py respectively). Excluding those with a BMI < 20kg/m2, there was a significant 195 
linear trend of increasing rate of hospitalisation with increasing BMI (p<0.0001 for both males 196 
and females).  197 
 198 
When examined separately by age group (Figure 2), while the absolute rates of hospitalisation 199 
rose with increasing age, as expected, the pattern of rising relative rates of hospitalisation with 200 
increasing BMI was attenuated with increasing age.  After adjustment for potential confounding 201 
variables (see Table 2), the trend of increasing hospitalisation with increasing above-normal 202 
BMI remained apparent with trends in both men and women stronger in the youngest age group 203 
(RR 1.04 per 1kg/m2 increase) and weaker in the 80+ age group (RR 1.01 per 1kg/m2 increase). 204 
Amongst those aged 45–64, the risk of hospitalisation for the severely obese group (BMI 35–205 
50kg/m2) was twice that of the group with normal BMI (male RR:1.86, 95%CI:1.69 to 2.05; 206 
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female RR:2.09; 95%CI:1.96 to 2.23), and amongst those aged 65–79 years the corresponding 207 
risks were 50–60% higher (Male RR:1.48, 95%CI:1.34 to 1.64; female RR:1.61; 95%CI:1.47 to 208 
1.76). In people aged 80 years or older, although risks were elevated in those with a BMI of 27.5 209 
kg/m2 or higher and the overall trend was significant, there was considerable overlap in the 210 
confidence intervals of these risk estimates. Additional adjustment for region of birth made no 211 
material difference to the results (not shown). The sensitivity analysis excluding the first year of 212 
follow-up (n=242,829; 39,821 events over 282,243 person-years) showed little change in the 213 
RRs (see Supplementary Table). 214 
  215 
To allow for closer examination of the effect of prior serious illness, smoking status and physical 216 
activity on the relationship between BMI and hospitalisation, age-adjusted rates are also 217 
presented separately for those with and without serious illness, by current, past and never 218 
smokers, and by tertile of physical activity  (Figure 3). This shows that the trend of increasing 219 
rate of hospitalisation as BMI increased from normal weight to severely obese was apparent 220 
regardless of history of prior serious illness, smoking status or physical activity level. These 221 
trends remained in the Cox regression analyses, following adjustment for potential confounding 222 
factors, and there was no significant difference in the relationship between BMI and 223 
hospitalisation in any sex/age group examined, except amongst males aged 45–64 224 
(p(interaction)=.002), where the strength of the relationship was weaker among current smokers 225 
than past or never smokers (RRs per 1kg/m2 increase in BMI where BMI>20kg/m2 of 1.02 226 
(1.01–1.03), 1.04 (1.03–1.05) and 1.04 (1.04–1.05), respectively), and  amongst males aged 227 
80+,  where the effect size was stronger in those with high than lower levels of physical activity 228 
(RRs per 1kg/m2 increase in BMI where BMI>20kg/m2 of 1.00 (0.98–1.01), 1.02 (1.01–1.03) and 229 
1.04 (1.02–1.05), in lowest, middle and top tertile of physical activity respectively).  230 
  231 
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The rates of hospitalisation due to specific diagnoses in overweight and obese individuals, 232 
relative to those of normal weight (18–<25 kg/m2), are presented in Table 3 for the three age 233 
groups (males and females combined). For most diagnoses there was an increased risk of 234 
hospitalisation associated with obesity and to a lesser extent overweight, with effect sizes 235 
generally weaker with increasing age. The diagnoses for which these relationships were 236 
particularly strong—i.e. where the effect sizes were at least moderate, showed a gradient from 237 
overweight to obese and were evident in both younger and older age groups—included 238 
diabetes, ischaemic heart disease, chest pain, diverticular disease, gallbladder disease, 239 
osteoarthritis, asthma (excluding 65-79 year age group), sleep apnoea, and cellulitis. Risks 240 
were also elevated in the 45–64 year old age group for atrial fibrillation and cerebrovascular 241 
disease, as well as for depression (a non-significant reverse trend was shown in the older 242 
people) and prolapsed uterus. Overweight/obesity appeared to be protective for two 243 
conditions—hernia and fracture (particularly in the 80+ age group). 244 
 245 
 246 
Discussion 247 
 248 
The risk of hospitalisation rises gradually with increasing above-normal BMI, in both men and 249 
women. This pattern of increasing risk is evident among past, current and never smokers and 250 
among both physically active and inactive people. The relative risks of hospitalisation 251 
associated with above-normal BMI are highest among younger mid-age adults (45–64 years), 252 
with the risk of hospitalisation amongst those with a BMI>35kg/m2 approximately double that of 253 
those with BMI 20–22.5 kg/m2. Relative risks are not as high in older mid-age people (65–79 254 
years) but are still substantial, while the pattern of increasing relative risk of hospitalisation with 255 
increasing above-normal BMI is fairly weak in older people (80 years and older). The increased 256 
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risk of hospitalisation associated with overweight and, to a greater extent, obesity is evident for 257 
a large range of conditions in all age groups, including those aged 80 years or more.  258 
 259 
Causality between BMI and hospitalisation cannot be confirmed in this study. However, the 260 
dose-response relationship between BMI and hospitalisation amongst those with a BMI≥25 261 
kg/m2, which remained after adjusting for a range of important confounders and after 262 
stratification for smoking and physical activity, and which was evident for a large range of 263 
causes consistent with previous evidence,4 supports a causal relationship. Together with the 264 
knowledge that hospitalisation is a costly and not uncommon event, and that there is a high 265 
prevalence of overweight and obesity in the population (in Australia, 40% of people aged 45 and 266 
over are overweight and 30% are obese22), the findings indicate that overweight, not just 267 
obesity, is a substantial contributor to health service use and health costs in the population.  268 
 269 
The findings of increasing risk of hospitalisation with increasing BMI are broadly consistent with 270 
other studies, which have shown that obesity, but less consistently overweight, is associated 271 
with increased rates of hospitalisation, in either the shorter or longer term.5-11 It is also broadly 272 
consistent with findings of stronger associations amongst mid-age than older people in some 273 
studies,9,11 although others have found no clear patterns with respect to age.6 While caution 274 
should be applied in interpreting the absolute value of BMI at which risk increases, the level at 275 
which risk of hospitalisation was lowest in this study—20–<25 in men and 18.5–<25kg/m2 in 276 
women—is also consistent with these previous studies, as well as with studies on BMI and 277 
incidence of disease4 and all-cause mortality.2,3 That risks were lowest in these ranges is also 278 
concordant with the WHO definition of 18.5–<25 kg/m2 being in the 'normal' range, with the 279 
exception that in our study risk was actually elevated in the low normal weight range (18.5–<20 280 
kg/m2) among the younger men. This may partly reflect reverse causality due to pre-existing 281 
 13 
 
disease, as hospitalisation rates were not elevated in this low normal weight range amongst 282 
people without serious pre-existing disease.  283 
 284 
We found overweight, and to a greater extent, obesity is associated with an increased risk of 285 
hospitalisation for a heterogeneous range of conditions. These included potentially life-286 
threatening diseases such as cardiovascular disease, stroke (in younger obese men), diabetes 287 
and asthma, and also common, high-cost and high-morbidity conditions, such as osteoarthritis, 288 
diverticular disease, dorsopathy, gallbladder disease, sleep apnoea and uterine prolapse. 289 
Although we also found above-normal BMI is associated with a reduced risk of hernia and 290 
fracture, particularly in the older age group, the sum total of the relationship between BMI and 291 
hospitalisation is adverse. While the association between obesity and most of these conditions 292 
is fairly well established 4,23-31 their investigation in a single population-based dataset is relatively 293 
novel and allows both a general perspective on the conditions associated with both obesity and 294 
overweight, as well as insights into the diagnoses underlying the observed elevation in overall 295 
hospitalisation rates.  296 
 297 
The 45 and Up Study is an order of magnitude larger than previous studies investigating the 298 
relationship of BMI to hospitalisation, enabling the risks associated with small incremental 299 
changes in BMI to be examined. This is particularly useful as dose-response relationships can 300 
provide a good indication of the magnitude of risk and likely causality. The inclusion of 301 
individuals aged over 80 also meant that we had the power to examine variations in risk in the 302 
very old, an increasingly important group as the population ages, yet one which is often 303 
excluded (or at best aggregated) in population health studies. Another advantage of the study 304 
was the ability to link to administrative records, allowing virtually complete, and objective, 305 
ascertainment of outcomes over time. Use of hospitalisation records meant we could capture 306 
the risks of both fatal and non-fatal serious diseases associated with BMI. The ability to link 307 
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these records to survey data meant that we were able to adjust for a range of factors other than 308 
BMI that might influence hospitalisation.  309 
 310 
A limitation of our study is that BMI was the only anthropometric measure available and this 311 
measurement was based on self-reported weight and height at recruitment. It is well established 312 
that people tend to underestimate their weight and overestimate their height (and hence their 313 
BMI).32 However, consistent with other studies, a validation study involving participants in the 45 314 
and Up Study revealed that the mean difference between self-reported and measured BMI was 315 
not large (on average -0.74kg/m2) and correlations between self-reported and measured height 316 
and weight were 0.95 and 0.99, respectively.33 This means that self-reported data are useful for 317 
research investigating the relative risks of disease and other health outcomes comparing 318 
incremental changes in BMI, and although bias in the relative risk estimates cannot be ruled out, 319 
a recent study using NHANES data showed that mortality relative risks based on self-reported 320 
BMI data were for the most part not significantly different from those based on measured BMI.34 321 
Further, BMI was only measured at one point in time, which does not take into account duration 322 
of obesity—this may enhance risk estimates over and above BMI level alone.35 Another 323 
limitation is that, like most population-based cohort studies, response rates were relatively low 324 
and the potential for a ‘healthy cohort effect’ means that the estimates of relative risks shown 325 
here are likely to be conservative. We estimated the age-adjusted total hospitalisation rates 326 
(excluding day-admissions) in the 45 and Up cohort (233 and 217 per 1,000 person years for 327 
males and females respectively) and found these were only 11–12% lower than for the rates in 328 
the Australian population of the same age (respectively, 263 and 246 per 1,000 person years).36 329 
Moreover, it is important to note that relative risks, comparing groups within the cohort, remain 330 
valid and can be generalised more broadly.37,38  331 
 332 
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It is evident from this and previous research that overweight and obesity is associated with an 333 
increase in the risk of hospitalisation across a large range of diagnoses. While it is reasonable 334 
to attribute at least part of the increased risk to increased adiposity, some caution should be 335 
applied. First, BMI is an imperfect measurement of adiposity and in different populations such 336 
as the young fit men with high muscle mass or the elderly, BMI alone may not be a good 337 
measure of adiposity. Second, although longitudinal in design, we cannot totally disentangle the 338 
effects of complex disease pathways, and in particular reverse causality. The effect of disease 339 
on subsequent weight loss is especially an issue for cancer-related diagnoses, although the 340 
relationship between BMI and hospitalisation remained even when those with a diagnosis of 341 
cancer and other serious illness prior to entry into the study were excluded, and also when the 342 
first year of follow-up was excluded. Any such reverse causality may lead to an underestimate 343 
of the effect of above-normal weight on hospitalisation. It can also lead to an overestimate of the 344 
effect of underweight and these effects are observed in studies with longer follow-up.2,3 In some 345 
cases, reverse causality may also work in the opposite direction, leading to an overestimation of 346 
effects. For example, with sleep apnoea not only has obesity been linked to an increased risk of 347 
developing this condition, but sleep apnoea can also lead to an increase in obesity.28 Even the 348 
relationship between obesity and cardiovascular disease is complex and not limited to the 349 
standard risk factors such as hypertension, dyslipidemia and diabetes.10 Some studies on BMI 350 
and hospitalisation adjust for pre-existing disease (such as cardiovascular disease and 351 
diabetes) to limit the possibility of reverse causality, but as pre-existing disease may lie on the 352 
causal pathway between above-normal BMI and hospitalisation, adjusting for these diseases 353 
could constitute over-adjustment and inappropriately attenuate risks.  354 
 355 
While previous studies have adjusted for smoking, there are concerns that because smoking is 356 
so strongly associated with illness, and also BMI, and the amount of smoking may be 357 
imperfectly measured, that simple adjustment for smoking is insufficient. By stratifying our 358 
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results according to smoking, we were able to show clearly the risks of hospitalisation 359 
associated with BMI independently from smoking status. Similarly, the relationship between 360 
physical activity, BMI and hospitalisation is complex, and by stratifying by physical activity we 361 
were able to show the effect of BMI on hospitalisation was evident regardless of physical activity 362 
level. That this finding was shown to hold even in the inactive population is important, as BMI as 363 
a measure of adiposity is most valid in this population.39  364 
  365 
It is unclear why the strength of the association between BMI and hospitalisation declines with 366 
increasing age; there are a number of possible explanations. First, in elderly people, BMI may 367 
not be a good measure of adiposity because as one ages, height decreases, and lean body 368 
mass decreases and adipose tissue increases without weight gain, with the possible 369 
development of sarcopenic obesity.40 There is also a greater probability of reverse causality 370 
because older people have a greater number of health conditions that result in weight loss. 371 
Second, a likely contribution to the decline in the association between BMI and hospitalisation 372 
with age is the survival effect, as those with higher BMIs and/or those most susceptible to the 373 
effects of BMI on health may have already died. Third, it may be possible that being overweight 374 
in later life confers a genuine health benefit, as frailty and underweight become increasingly 375 
important contributors to ill health. Finally, the number of people in the oldest age group, 376 
particularly those with high BMIs, is limited, resulting in reduced power in the elderly.  377 
Importantly it should be kept in mind that while relative risks were lower in older than younger 378 
people, this may not necessarily translate to a lower absolute burden of hospitalisation 379 
attributable to overweight/obesity in older people than younger people; burden must also take 380 
into account the age-specific prevalence of overweight and obesity in the population (which is 381 
lowest in those age 80+) and the absolute rates of hospitalisation (which are highest amongst 382 
those aged 80+). 383 
 384 
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There has been some uncertainty about the relationship between BMI and risk of disease and 385 
hospitalisation, in particular regarding the level of BMI at which risk starts to increase in the 386 
population, and whether the risk associated with obesity persists in the elderly. The incremental 387 
nature of the increasing risk of hospitalisation above the normal range of BMI found in this study 388 
shows that at the population level, even mild overweight increases risk, especially amongst 389 
those aged below 80 years of age. That a dose-response relationship was found after 390 
adjustment for a range of important confounders gives strength to the argument that above-391 
normal BMI is causally linked to many diseases. The findings suggest that, all else being equal, 392 
populations with even a minor difference in the BMI distribution toward lower values could have 393 
substantially lower hospitalisation rates. 394 
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Figure Legends 515 
Figure 1. Age-standardised incident hospitalisation rates by body mass index (BMI) 516 
Figure 2. Age-standardised incident hospitalisation rates (with 95% CI) by body mass index 517 
(BMI), stratified by sex and age group 518 
Figure 3. Age-standardised hospitalisation rates by body mass index (BMI), stratified by  (a) 519 
prior history of serious illness;  (b) smoking status and (c) tertile of physical activity 520 
 521 
 522 
 523 
 524 
Table 1.  Characteristics of the study population (%)1 by category of body mass index (BMI)  
 
BMI Category 
  
 Under-
weight 
 
Normal weight 
 
Overweight 
 
Obese 
  
 
15-<18.5 
 
18.5-<20 20-<22.5 22.5-<25 
 
25-<27.5 27.5-<30 
 
30-<32.5 32.5-<35 35-50 
 Total 
sample 
n 3 107  6 834 30 180 53 756  55 694 41 740  25 544 13 773 15 733  246 361 
% of total 1.3  2.8 12.3 21.8  22.6 16.9  10.4 5.6 6.4  100 
 
 
 
   
 
  
 
   
  
Male 24.9  22.2 32.0 45.5  55.1 56.9  51.3 46.0 35.1  47.0 
45-64 yrs 49.6  60.1 61.9 59.3  59.8 61.8  64.6 66.9 72.9  61.9 
65-79 yrs 26.0  23.0 24.4 28.5  30.4 30.7  29.0 28.2 23.8  28.3 
80 yrs 24.4  16.9 13.7 12.2  9.9 7.6  6.4 4.9 3.3  9.8 
Lives in major city 48.1  50.6 48.9 47.7  45.3 43.5  42.4 40.5 39.4  45.2 
Income >=$70K2 17.2  28.2 30.7 31.9  32.5 31.5  29.2 27.9 25.0  30.6 
University degree 21.1  27.1 28.5 27.3  24.9 22.2  19.9 17.7 16.3  24.0 
Health insurance3 56.2  62.6 66.4 67.7  67.9 66.6  64.2 61.2 56.5  65.7 
High PA4 37.6  38.3 40.2 38.5  36.2 33.1  29.6 26.7 22.6  34.7 
Current smoker 16.6  11.0 9.1 7.2  6.3 6.3  6.7 7.1 7.3  7.2 
Alcohol 15+ p/w5  9.0  8.6 10.5 13.6  16.6 17.5  16.5 15.2 10.8  14.6 
Note. 1. Percentage of sample within BMI category unless indicated otherwise; participants with missing values are not included in the percentages (% missing: area=0.1%; 
income=20.9%; education=1.4%; physical activity=1.9%; smoking=0.3%; alcohol=1.9%; other variables=0 missing); percentages may not total 100 due to rounding.  2. 
Annual pre-tax household income in Australian dollars. 3. Includes private health insurance or Department of Veterans Affairs health card. 4. Top tertile of physical activity. 
5. 15 or more alcoholic drinks per week. 
 
Table 2. Adjusted relative risks (RR)1 of hospitalisation by body mass index (BMI), stratified by sex and age group  
  45-64 years  65-79 years  80 years or older 
BMI    n(2) py RR 95% CI p  n(2) py RR 95% CI p  n(2) py RR 95% CI p 
  
 Males 
15-<18.5  77 693 1.26 0.99–1.59 .056  90 346 1.36 1.10–1.69 .005  140 299 1.34 1.10–1.64 .003 
18.5-<20  140 1510 1.19 0.99–1.42 .063  161 762 1.14 0.96–1.35 .125  204 555 1.10 0.94–1.29 .238 
20-<22.5  740 9916 1.00 – –  990 5490 1.00 – –  1056 3175 1.00 – – 
22.5-<25  2045 26905 1.04 0.96–1.14 .322  2587 14817 0.99 0.92–1.06 .688  1885 6002 0.97 0.90–1.06 .507 
25-<27.5  3024 36149 1.13 1.05–1.23 .002  3405 18463 1.05 0.98–1.13 .163  1642 5138 1.01 0.93–1.10 .814 
27.5-<30  2673 29218 1.21 1.12–1.32 <.001  2671 13762 1.10 1.02–1.19 .009  949 2791 1.05 0.96–1.16 .279 
30-<32.5  1776 16578 1.38 1.27–1.50 <.001  1529 6947 1.26 1.17–1.37 <.001  458 1243 1.13 1.00–1.27 .048 
32.5-<35  960 8132 1.49 1.35–1.64 <.001  733 3278 1.28 1.16–1.41 <.001  172 424 1.29 1.08–1.53 .004 
35-50  1088 7288 1.86 1.69–2.05 <.001  639 2464 1.48 1.34–1.64 <.001  93 249 1.17 0.94–1.46 .157 
                   
Trend3    1.04 1.03–1.04 <.001    1.03 1.02–1.03 <.001    1.01 1.00–1.01 .033 
 
 Females 
15-<18.5  178 2564 1.06 0.91–1.24 .434  200 1100 1.22 1.05–1.42 .010  280 781 1.13 0.99–1.29 .072 
18.5-<20  433 7120 0.99 0.89–1.10 .868  320 2172 1.04 0.92–1.18 .519  396 1212 1.08 0.96–1.21 .209 
20-<22.5  1802 29685 1.00 – –  1208 8540 1.00 – –  997 3315 1.00 – – 
22.5-<25  2649 40384 1.05 0.99–1.12 .087  1985 14276 1.00 0.93–1.07 .991  1283 4484 0.99 0.91–1.07 .789 
25-<27.5  2490 33162 1.18 1.11–1.25 <.001  1906 13081 1.04 0.97–1.12 .279  1019 3572 0.99 0.91–1.08 .812 
27.5-<30  2063 23178 1.38 1.30–1.47 <.001  1559 9661 1.16 1.08–1.25 <.001  664 2108 1.11 1.00–1.22 .046 
30-<32.5  1673 16459 1.55 1.45–1.65 <.001  1073 6245 1.22 1.13–1.33 <.001  388 1221 1.11 0.99–1.25 .078 
32.5-<35  1159 9939 1.76 1.63–1.90 <.001  683 3505 1.39 1.27–1.53 <.001  181 590 1.06 0.91–1.25 .458 
35-50  2021 14432 2.09 1.96–2.23 <.001  864 3896 1.61 1.47–1.76 <.001  182 493 1.31 1.12–1.54 .001 
                   
Trend3    1.04 1.04–1.05 <.001    1.03 1.03–1.04 <.001    1.01 1.01–1.02 .001 
Notes. 1. Adjusted for age, region of residence, household income, smoking, alcohol intake and private health insurance status. 2. n refers to 
number of incident hospitalisations; py=person years.  3. Trend: Test for trend where BMI>20kg/m2; RR refers to the increase in rate per 1kg/m2 
increase in BMI. 
Table 3. Adjusted relative risks of diagnosis-specific hospitalisation by BMI category, by age group, males and females combined  
 
45–64 years 
 
65–79 years 
 
80 years or older 
 
No. events 
norm/ow/ob2 
Relative Risks1  
(95% CI) 
 
No. events 
norm/ow/ob2 
Relative Risks1  
(95% CI) 
 
No. events 
norm/ow/ob2 
Relative Risks1  
(95% CI) 
  
Overweight Obese 
 
 
Overweight Obese 
 
 
Overweight Obese 
Diabetes 49/77/191 1.27 4.35 83/180/196 1.72 3.76 93/103/43 1.45 1.94 
(E10-E14) 
 
0.89–1.82 3.16–5.98 
  
1.32–2.23 2.90–4.88 
  
1.09–1.92 1.34–2.80 
Circulatory diseases 
           Ischaemic heart disease 340/715/609 1.548 2.128 
 
688/1071/603 1.19 1.45 
 
564/469/157 1.10 1.23 
(I20–I25) 
 
1.35–1.75 1.85–2.43 
  
1.08–1.31 1.30–1.62 
 
 0.97–1.24 1.03–1.47 
Atrial fibrillation 121/215/174 1.37 1.84 
 
271/344/206 1.07 1.33 
 
275/203/71 1.04 1.15 
(I48) 
 
1.09–1.72 1.45–2.33 
  
0.91–1.26 1.11–1.60 
 
 0.87–1.25 0.88–1.50 
Cerebrovascular disease 149/185/153 1.00 1.31 
 
381/428/210 0.91 0.96 
 
464/329/98 0.99 0.97 
(I60–I69, G45, G46) 
 
0.80–1.25 1.04–1.66 
  
0.79–1.05 0.81–1.15 
 
 0.86–1.14 0.78–1.21 
Chest pain 363/594/542 1.48 1.99 
 
345/537/337 1.26 1.52 
 
231/198/70 1.13 1.23 
(R07, excl. R07.0) 
 
1.29–1.69 1.74–2.28 
  
1.10–1.45 1.31–1.77 
 
 0.93–1.36 0.94–1.62 
Respiratory diseases 
        
 
  Coronary obstructive 84/89/105 0.94 1.31 
 
245/189/178 0.60 1.05 
 
230/177/64 0.98 1.13 
 pulmonary disease (J41–J44) 
 
0.70–1.27 0.98–1.76 
  
0.49–0.72 0.86–1.28 
 
 0.81–1.20 0.85–1.49 
Asthma 24/52/70 2.30 3.97 
 
30/28/32 0.84 1.64 
 
13/15/11 1.69 3.06 
(J45–J46) 
 
1.41–3.75 2.48–6.36 
  
0.50–1.41 0.98–2.73 
 
 0.80–3.56 1.35–6.94 
Pneumonia (incl. influenza) 153/205/191 1.12 1.49 
 
275/315/195 0.89 1.11 
 
418/250/95 0.83 1.04 
(J09–J18) 
 
0.90–1.39 1.19–1.85 
  
0.76–1.05 0.92–1.34 
 
 0.71–0.97 0.83–1.30 
Digestive diseases 
        
 
  Diverticular disease 77/118/126 1.42 2.18 
 
87/124/105 1.20 1.97 
 
71/71/26 1.40 1.57 
(K57) 
 
1.06–1.90 1.63–2.91 
  
0.91–1.58 1.47–2.63 
 
 1.01–1.95 1.00–2.48 
Gallbladder disease3 219/350/375 1.71 2.87 
 
134/257/137 1.67 1.84 
 
89/89/30 1.41 1.43 
(K80) 
 
1.44–2.03 2.42–3.40 
  
1.35–2.06 1.45–2.35 
 
 1.05–1.90 0.94–2.17 
Hernia 327/380/134 0.71 0.48 
 
354/396/74 0.76 0.34 
 
187/113/15 0.72 0.36 
(K40) 
 
0.61–0.82 0.39–0.59 
  
0.66–0.88 0.26–0.44 
 
 0.57–0.92 0.21–0.61 
Musculoskeletal diseases 
        
 
  Osteoarthritis 383/745/929 1.67 3.32 
 
563/1124/822 1.69 2.59 
 
307/332/122 1.46 1.67 
(M15–M19; M47) 
 
1.47–1.89 2.94–3.75 
  
1.53–1.88 2.32–2.89 
 
 1.25–1.71 1.35–2.07 
Dorsopathy 286/418/360 1.31 1.73 
 
276/408/232 1.24 1.45 
 
200/189/70 1.36 1.56 
(M40–M54) 
 
1.12–1.52 1.47–2.02 
  
1.07–1.45 1.21–1.73 
 
 1.11–1.66 1.19–2.06 
Soft tissue disorders 290/460/427 1.29 1.90 
 
185/319/192 1.33 1.66 
 
68/61/18 1.19 1.14 
(M60–M79) 
 
1.11–1.50 1.63–2.21 
  
1.11–1.59 1.35–2.04 
 
 0.84–1.68 0.67–1.93 
Cancer 
        
 
  Any cancer (excl. skin) 823/972/639 1.00 1.03 
 
877/1130/569 0.99 1.07 
 
611/481/143 1.05 1.04 
(C00-C97, excl C43–C44) 
 
0.91–1.10 0.93–1.14 
  
0.91–1.09 0.96–1.19 
 
 0.93–1.18 0.87–1.25 
Any cancer — excl. previous4 610/737/490 1.04 1.10 
 
602/798/428 1.05 1.20 
 
431/325/103 1.03 1.09 
  
0.93–1.16 0.97–1.24 
  
0.94–1.17 1.06–1.36 
 
 0.89–1.20 0.87–1.35 
Other 
        
 
  Sleep Apnoea 134/341/421 2.07 4.62 
 
62/169/175 1.95 4.99 
 
25/40/18 1.98 3.47 
(G47.3) 
 
1.69–2.54 3.79–5.62 
  
1.45–2.61 3.71–6.69 
 
 1.19–3.28 1.88–6.42 
Cellulitis 83/140/189 1.41 2.94 
 
104/158/156 1.23 2.55 
 
144/124/62 1.23 1.94 
(L03) 
 
1.07–1.86 2.26–3.82 
  
0.96–1.58 1.98–3.28 
 
 0.97–1.57 1.44–2.63 
Depression 95/101/105 1.06 1.60 
 
48/46/27 0.80 0.87 
 
33/19/6 0.79 0.72 
(F32–F33) 
 
0.80–1.41 1.21–2.12 
  
0.53–1.20 0.54–1.41 
 
 0.45–1.39 0.30–1.74 
Fracture  424/427/255 0.92 0.85 
 
426/372/191 0.83 0.80 
 
653/302/85 0.69 0.58 
(ICD codes – see note5) 
 
0.80–1.05 0.72–0.99 
  
0.72–0.95 0.67–0.95 
 
 0.61–0.80 0.46–0.73 
Benign prostatic hyperplasia6 99/167/113 0.95 1.24 
 
219/309/135 0.94 1.04 
 
126/97/26 0.95 1.00 
(N40) 
 
0.74–1.22 0.94–1.63 
  
0.79–1.12 0.83–1.29 
 
 0.73–1.25 0.65–1.54 
Prolapse of the uterus7 163/172/118 1.44 1.36 
 
84/112/61 1.50 1.37 
 
20/15/4 1.13 0.74 
(N81) 
 
1.16–1.78 1.07–1.74 
  
1.13–2.00 0.98–1.92 
 
 0.57–2.22 0.25–2.18 
Notes. 1. Adjusted for sex, age, region of residence, household income, smoking, alcohol intake and private health insurance status; reference group is normal weight (20–
25 kg/m2).  2. No. events=total diagnosis-specific incident hospitalisations in that age group for normal/overweight/obese.  3. Excludes those who reported at baseline 
having had their gallbladder removed. 4. Excludes participants with diagnosis of cancer on cancer registry prior to enrolment in study. 5. ICD codes for fracture: S02, S12, 
S22.0, S22.1, S22.2, S22.3, S22.4, S22.8, S22.9, S32, S42, S52, S62, S72, S82, S92, T02, T08, T10, T12, T14.26. 6. Excludes women and those who reported at baseline having 
had a partial or total prostatectomy.  7. Excludes men and those who reported at baseline having had a hysterectomy. 8. Proportional hazards assumption not satisfied, but 
was when males and females analysed separately, with HRs for overweight and obese in males being 1.50 (95%CI: 1.28–1.76) and 2.08 (1.76–2.46) and for females 1.55 
(1.23–1.96) and 2.09 (1.66–2.62). 
 
Figure 1. Age-standardised incident hospitalisation rates by body mass index (BMI) 
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Notes. 1. Median BMI of each category. 2. Test for trend where BMI>20kg/m2 , p <0.001 for both males 
and females . 
 
 
Figure 2. Age-standardised incident hospitalisation rates (with 95% CI) by body mass index 
(BMI), stratified by sex and age group 
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Notes. 1. Median BMI of each category. 2. Test for trend where BMI>20kg/m2. 3. Different scales used 
across age groups.
Test for trend: p<0.001 Test for trend: p<0.001 Test for trend: p<.001 
Test for trend: p<0.001 Test for trend: p<0.001 Test for trend: p<.001 
Figure 3. Age-standardised hospitalisation rates (with 95% CI) by body mass index (BMI), 
stratified by  (a) prior history of serious illness;  (b) smoking status and (c) tertile of physical 
activity 
(a) Stratified by prior history of prior serious illness 
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(b) Stratified by smoking status 
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                Current smoker           Past smoker             Never smoked 
             Serious prior illness                No serious prior illness 
(c) Stratified by physical activity 
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Notes. 1. Median BMI of each category.  2. Prior serious illness includes circulatory disease, diabetes, 
coronary obstructive pulmonary disease and cancer. 3.  Test for trend where BMI>20kg/m2, p<0.001 for 
all strata of illness, smoking and physical activity, in both males and females. 
 
                 Tertile 1- low            Tertile 2              Tertile 3 - high 
